Authorization

CES 2021 Mission for the human race, Pulxion's early detection technology is here to save lives

TAIPEI, Jan. 14, 2021 /PRNewswire/ -- In the new era of medical technology,A Pulxion Medical Technology Co., Ltd. aims to create a personalized mobile hospital to enable early detection and achieve preventive healthcare in everyday life. Pulxion's first product, PulStroke, is a novel fast-screening device for carotid artery stenosis, an early indicator of stroke. In the near future, Pulxion will expand its algorithm application to include arteriovenous fistula stenosis.Stroke is a top-five leading cause of death in the world. Ischemic stroke is one of the two major types of stroke, accounting for 85% of stroke deaths. Current clinical diagnosis procedures for early detection of carotid artery stenosis risk use Doppler ultrasound. However, ultrasound relies heavily on medical professionals to perform and interpret, making it not only time consuming but also location limiting. Therefore, patients without existing conditions are less willing to go through the assessment and thus lose the chance for early assessment and prevention.PulStroke integrates AI algorithm technology for accurate and faster screenings.A  PulStroke is a non-invasive, non-radioactive, user-friendly, and easy-to-operate assessment tool. With PulStroke, screening results can be accessed by users via the device or users' smartphones within 5 minutes. The device first records a 20-second clip of the user's anterior neck skin under LED light. Then, the cloud algorithm analyzes the data and delivers screening results to the users. The accuracy of PulStroke is better than 90% the accuracy of the Doppler ultrasound method. Mapping the steady growth of the team
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Январь 2021    »
ПнВтСрЧтПтСбВс
 123
45678910
11121314151617
18192021222324
25262728293031